CO2 Detector for Neonatal Resuscitation
(CO2-Vent Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a device called Pedi-Cap can assist newborns needing breathing support immediately after birth. The Pedi-Cap, a color-changing tool, helps doctors and nurses check if a baby is exhaling carbon dioxide properly, potentially reducing the time the baby requires breathing assistance. Some newborns will receive care with the Pedi-Cap, while others will not, to compare outcomes. Babies born at or after 30 weeks who need breathing support are suitable candidates for this trial. As an unphased trial, this study provides a unique opportunity to contribute to important research that could enhance newborn care.
Do I need to stop my current medications for this trial?
The trial does not specify whether participants need to stop taking their current medications.
What prior data suggests that the Pedi-Cap CO2 Detector is safe for neonatal resuscitation?
Research has shown that CO2 detectors, such as the Pedi-Cap, are safely used in newborns during resuscitation. These devices help ensure correct placement of breathing tubes by changing color with each breath, allowing the medical team to monitor the baby's breathing. Studies have found that using these detectors can reduce complications in infants, particularly those at risk of changes in blood flow to the brain. This indicates that the Pedi-Cap is generally well-tolerated in newborns, with no major safety concerns reported.12345
Why are researchers excited about this trial?
Researchers are excited about the Pedi-Cap because it introduces an innovative way to assess effective neonatal resuscitation by using color change to indicate carbon dioxide (CO2) exchange. Unlike standard methods that rely solely on monitoring heart rate, infant color, chest rise, and oxygen saturation, the Pedi-Cap provides immediate visual confirmation of effective ventilation through a simple color shift from purple to gold with each exhalation. This real-time feedback can help the resuscitation team quickly determine if a newborn is receiving adequate non-invasive positive pressure ventilation (PPV), potentially improving response times and outcomes in critical delivery room situations.
What evidence suggests that the Pedi-Cap CO2 Detector is effective for neonatal resuscitation?
In this trial, some participants will use the Pedi-Cap, a device that changes color, during newborn resuscitation. Studies have shown that the Pedi-Cap turns gold before a baby's heart rate significantly increases, confirming that the baby receives enough air. This helps the resuscitation team determine if they provide sufficient air to the baby. Additionally, it has proven effective in confirming the correct placement of breathing tubes in newborns. The Pedi-Cap offers immediate feedback, leading to faster and more accurate resuscitation efforts.13467
Who Is on the Research Team?
Riti Chokshi
Principal Investigator
University of Texas
Are You a Good Fit for This Trial?
This trial is for newborn infants born at or after 30 weeks' gestation who need non-invasive positive pressure ventilation (PPV) in the delivery room. The neonatal resuscitation team must be present before delivery to participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Neonatal resuscitation team uses or does not use the Pedi-Cap during face mask PPV for infants born at ≥30 weeks' gestation in the delivery room
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessment of mechanical ventilation duration and need for NICU admission
Survey
Resuscitation team members complete a survey to assess their experience with each study arm
What Are the Treatments Tested in This Trial?
Interventions
- Pedi-Cap
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Texas Southwestern Medical Center
Lead Sponsor